Urokinase; protein-chemistry and fibrin-autography studies
Andrassy, K.; Seidel, D.; Buchholz, L.; Ritz, E.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1460-1462
1972
ISSN/ISBN: 0070-4067 PMID: 4665583 Document Number: 48056
Document emailed within 1 workday
Related Documents
Ueno, T.; Kobayashi, N.; Maekawa, T. 1979: Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase Thrombosis and Haemostasis 42(3): 885-894Pannell, R.; Angles-Cano, E.; Gurewich, V. 1990: The pH dependence of the binding of pro-urokinase to fibrin/celite Thrombosis and Haemostasis 64(4): 556-558
Kurokawa, T.; Iwasa, S.; Kakinuma, A.; Stassen, J.M.; Lijnen, H.R.; Collen, D. 1991: Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator Thrombosis and Haemostasis 66(6): 684-693
Hisano, S. 1978: Immunofluorescence study on thrombolysis with special reference to the patterns of distribution and the contents of fibrin, plasminogen, alpha2-macroglobulin and urokinase in artificial thrombi Thrombosis and Haemostasis 39(1): 53-60
Dewerchin, M.; Vandamme, A.M.; Holvoet, P.; De Cock, F.; Lemmens, G.; Lijnen, H.R.; Stassen, J.M.; Collen, D. 1992: Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase Thrombosis and Haemostasis 68(2): 170-179
Dybkaer, R. 1979: International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. IUPAC Section on Clinical Chemistry Commission on Quantities and Units in Clinical Chemistry and IFCC Committee on Standards Expert Panel on Quantities and Units approved recommendation (1978). List of quantities in clinical chemistry Journal of Clinical Chemistry and Clinical Biochemistry 17(12): 822-835
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
O'Connor, J.V.; Keck, R.G.; Harris, R.J.; Field, M.J. 1994: New techniques in protein chemistry Developments in Biological Standardization 83: 165-173
Kirchheimer, J.C.; Nong, Y.H.; Remold, H.G. 1988: IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes Journal of Immunology 141(12): 4229-4234
Shiba, T.; Igarashi, M.; Takeuchi, S.; Awazu, S.; Asada, T. 1978: Experimental and clinical studies on thrombolytic therapy with urokinase Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(4): 771-781
Collen, D.; De Cock, F.; Lijnen, H.R. 1984: Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys Thrombosis and Haemostasis 52(1): 24-26
Geratz, J.D.; Shaver, S.R.; Tidwell, R.R. 1981: Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation Thrombosis Research 24(1-2): 73-83
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B. 1982: Factor VIIi concentrates. Problems and protein chemistry characterization Die Medizinische Welt 33(28): 1027-1033
Dayi, H.; Zhimin, X. 1997: Evaluation of the patency rate of infarct-related artery after intravenous urokinase in acute myocardial infarction by 90 minutes angiography. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(3): 184-186
Facchini, M.; Guldenschuh, I.; Turina, J.; Jenni, R.; Schalcher, C.; Attenhofer Jost, C.H. 2000: Resolution of protein-losing enteropathy with standard high molecular heparin and urokinase after Fontan repair in a patient with tricuspid atresia Journal of Cardiovascular Surgery 41(4): 567-570
Kawamura, M.; Urist, M.R. 1988: Human fibrin is a physiologic delivery system for bone morphogenetic protein Clinical Orthopaedics and Related Research 235: 302-310
Nickerson, J.M.; Borst, D.E.; Redmond, T.M.; Si, J.S.; Toffenetti, J.; Chader, G.J. 1991: The molecular biology of IRBP: application to problems of uveitis, protein chemistry, and evolution Progress in Clinical and Biological Research 362: 139-161
Ren, Y.-l.; Yang, J.-s. 2002: Studies on the chemistry of two new compounds of Hemistepta lyrata Yao Xue Xue Bao 37(6): 440-443
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
Mahn, I.; von Drach, H.; Müller-Berghaus, G. 1976: In-vivo studies on the elimination of various soluble fibrin-preparations Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1643-1646